Intraventricular Tigecycline as a Last Resort Therapy in a Patient with Difficult-to-Treat Healthcare-Associated <i>Acinetobacter baumannii</i> Ventriculitis: a Case Report.

Abdallah, Mohammad; Alsaleh, Hamzeh; Baradwan, Abdallah; Alfawares, Reem; Alobaid, Abdulaziz; Rasheed, Akram; Soliman, Ibrahim

Intraventricular Tigecycline as a Last Resort Therapy in a Patient with Difficult-to-Treat Healthcare-Associated Acinetobacter baumannii Ventriculitis: a Case Report.

Abdallah, Mohammad; Alsaleh, Hamzeh; Baradwan, Abdallah; Alfawares, Reem; Alobaid, Abdulaziz; Rasheed, Akram; Soliman, Ibrahim.

Afiliação

Abdallah M; Pharmaceutical Care Services, King Saud Medical City, Riyadh, Saudi Arabia.
Alsaleh H; Pharmacy Department, Hamad Medical Corporation, Doha, Qatar.
Baradwan A; The Division of Infectious Diseases, King Saud Medical City, Riyadh, Saudi Arabia.
Alfawares R; Doha, Qatar.
Alobaid A; Pharmaceutical Care Services, King Saud Medical City, Riyadh, Saudi Arabia.
Rasheed A; Department of Nursing Education and Development, King Saud Medical City, Riyadh, Saudi Arabia.
Soliman I; Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.

SN Compr Clin Med ; 2(9): 1683-1687, 2020.

Article em En | MEDLINE | ID: mdl-32838183

Palavras-chave

Acinetobacter baumannii; Anaphylactoid reaction; Intraventricular; Tigecycline; Ventriculitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: SN Compr Clin Med Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google